Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
Nobumichi Ohoka, Keiichiro Okuhira, Masahiro Ito, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 11, pp. 4556-4570
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson, Blake E. Smith, George M. Burslem, et al.
Cell chemical biology (2017) Vol. 25, Iss. 1, pp. 78-87.e5
Open Access | Times Cited: 753
Targeted protein degradation: expanding the toolbox
Matthieu Schapira, Matthew F. Calabrese, Alex N. Bullock, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 12, pp. 949-963
Closed Access | Times Cited: 718
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Mariell Pettersson, Craig M. Crews
Drug Discovery Today Technologies (2019) Vol. 31, pp. 15-27
Open Access | Times Cited: 601
PROTACs: great opportunities for academia and industry
Xiuyun Sun, Hongying Gao, Yiqing Yang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 513
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi, Jun Moriyama, Tomoe Y. Nakamura, et al.
Molecular Cell (2019) Vol. 76, Iss. 5, pp. 797-810.e10
Open Access | Times Cited: 449
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Ian Churcher
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 2, pp. 444-452
Closed Access | Times Cited: 390
Development of targeted protein degradation therapeutics
Philip P. Chamberlain, Lawrence G. Hamann
Nature Chemical Biology (2019) Vol. 15, Iss. 10, pp. 937-944
Closed Access | Times Cited: 388
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Philipp M. Cromm, Craig M. Crews
Cell chemical biology (2017) Vol. 24, Iss. 9, pp. 1181-1190
Open Access | Times Cited: 351
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha, Craig M. Crews
Cell chemical biology (2020) Vol. 27, Iss. 8, pp. 998-1014
Open Access | Times Cited: 335
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 329
Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
Scott D. Edmondson, Bin Yang, Charlene Fallan
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 13, pp. 1555-1564
Closed Access | Times Cited: 318
Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
Alexandru D. Buhimschi, Haley A. Armstrong, Momar Toure, et al.
Biochemistry (2018) Vol. 57, Iss. 26, pp. 3564-3575
Closed Access | Times Cited: 316
Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
Sainan An, Liwu Fu
EBioMedicine (2018) Vol. 36, pp. 553-562
Open Access | Times Cited: 303
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman, et al.
Cell (2020) Vol. 183, Iss. 6, pp. 1714-1731.e10
Open Access | Times Cited: 285
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Degradation of proteins by PROTACs and other strategies
Yang Wang, Xueyang Jiang, Feng Feng, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 2, pp. 207-238
Open Access | Times Cited: 255
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
SLAS DISCOVERY (2020) Vol. 26, Iss. 4, pp. 484-502
Open Access | Times Cited: 255
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 251
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
Jiantao Hu, Biao Hu, Mingliang Wang, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 3, pp. 1420-1442
Closed Access | Times Cited: 233
The PROTAC technology in drug development
Yutian Zou, Danhui Ma, Yinyin Wang
Cell Biochemistry and Function (2019) Vol. 37, Iss. 1, pp. 21-30
Open Access | Times Cited: 226
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
Chiara Maniaci, Scott J. Hughes, Andrea Testa, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 215
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 189
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Xinyi Li, Wenchen Pu, Qingquan Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 188
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Rati Verma, Dane Mohl, Raymond J. Deshaies
Molecular Cell (2020) Vol. 77, Iss. 3, pp. 446-460
Open Access | Times Cited: 171
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 170
Page 1 - Next Page

Scroll to top